Growth Metrics

Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2026)

Vanda Pharmaceuticals recorded quarterly Exchange Rate Effect of -$57000.0 in Q1 2026, down 385.0% quarter-over-quarter from $20000.0 in Q4 2025, and down 216.33% year-over-year from $49000.0 in Q1 2025.

Vanda Pharmaceuticals' Exchange Rate Effect history runs 10 years deep, the most recent figure standing at -$57000.0 for Q1 2026.

  • In Q1 2026, Exchange Rate Effect fell 216.33% year-over-year to -$57000.0; the TTM figure through Mar 2026 stood at -$83000.0 (up 17.0% YoY), while the FY2025 annual figure was $23000.0, up 114.11% from the prior year.
  • Exchange Rate Effect came in at -$57000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $20000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $183000.0 in Q4 2022 to a low of -$202000.0 in Q4 2024.
  • A 5-year average of $6764.7 and a median of $20000.0 in 2025 frame the typical range for Exchange Rate Effect.
  • On a YoY basis, Exchange Rate Effect climbed as much as 993.33% in 2025 and fell as far as 364.71% in 2025.
  • Vanda Pharmaceuticals' Exchange Rate Effect stood at $183000.0 in 2022, then declined by 18.03% to $150000.0 in 2023, then tumbled by 234.67% to -$202000.0 in 2024, then surged by 109.9% to $20000.0 in 2025, then slumped by 385.0% to -$57000.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered -$57000.0, $20000.0, and -$180000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.60 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -40.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -900,000.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -7.06 Mn
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -57,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -57,000.00
Mar 31, 2026 -57,000.00
Dec 31, 2025 20,000.00
Dec 31, 2025 20,000.00
Sep 30, 2025 -180,000.00
Sep 30, 2025 -180,000.00
Jun 30, 2025 134,000.00
Jun 30, 2025 134,000.00
Mar 31, 2025 49,000.00
Mar 31, 2025 49,000.00
Dec 31, 2024 -202,000.00
Dec 31, 2024 -202,000.00
Sep 30, 2024 68,000.00
Sep 30, 2024 68,000.00
Jun 30, 2024 -15,000.00
Jun 30, 2024 -15,000.00
Mar 31, 2024 -14,000.00
Mar 31, 2024 -14,000.00
Dec 31, 2023 150,000.00
Dec 31, 2023 150,000.00
Sep 30, 2023 -122,000.00
Sep 30, 2023 -122,000.00
Jun 30, 2023 -26,000.00
Jun 30, 2023 -26,000.00
Mar 31, 2023 45,000.00
Mar 31, 2023 45,000.00
Dec 31, 2022 183,000.00
Dec 31, 2022 183,000.00
Sep 30, 2022 60,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 79,000.00
Jun 30, 2022 79,000.00
Mar 31, 2022 -57,000.00
Mar 31, 2022 -57,000.00
Dec 31, 2021 -101,000.00
Dec 31, 2021 -101,000.00
Sep 30, 2021 39,000.00
Sep 30, 2021 39,000.00
Jun 30, 2021 -14,000.00
Jun 30, 2021 -14,000.00
Mar 31, 2021 -15,000.00
Mar 31, 2021 -15,000.00
Dec 31, 2020 12,000.00
Dec 31, 2020 12,000.00
Sep 30, 2020 18,000.00
Sep 30, 2020 18,000.00
Jun 30, 2020 18,000.00
Jun 30, 2020 18,000.00
Mar 31, 2020 5,000.00
Mar 31, 2020 5,000.00
Dec 31, 2019 23,000.00
Dec 31, 2019 23,000.00
Sep 30, 2019 -19,000.00
Sep 30, 2019 -19,000.00
Jun 30, 2019 -7,000.00
Jun 30, 2019 -7,000.00
Mar 31, 2019 2,000.00
Mar 31, 2019 2,000.00
Dec 31, 2018 -24,000.00
Dec 31, 2018 -24,000.00
Sep 30, 2018 -14,000.00
Sep 30, 2018 -14,000.00
Jun 30, 2018 -18,000.00
Jun 30, 2018 -18,000.00
Mar 31, 2018 18,000.00
Mar 31, 2018 18,000.00
Dec 31, 2017 8,000.00
Dec 31, 2017 8,000.00
Sep 30, 2017 14,000.00
Sep 30, 2017 14,000.00
Jun 30, 2017 19,000.00
Jun 30, 2017 19,000.00
Mar 31, 2017 1,000.00
Mar 31, 2017 1,000.00